NUPROBE
NuProbe is a cutting-edge genomics and molecular diagnostics company.
NUPROBE
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.nuprobe.com
Total Employee:
11+
Status:
Active
Total Funding:
103 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Investors List
Sequoia Capital China
Sequoia Capital China investment in Series B - NuProbe
Pan-Lin Capital
Pan-Lin Capital investment in Series B - NuProbe
BioTrack Capital
BioTrack Capital investment in Series B - NuProbe
CR-CP Life Science Fund
CR-CP Life Science Fund investment in Series B - NuProbe
Deguan Capital
Deguan Capital investment in Series B - NuProbe
Yonghua Capital
Yonghua Capital investment in Series B - NuProbe
Haoreng Capital
Haoreng Capital investment in Series B - NuProbe
CICC Healthcare Investment Fund
CICC Healthcare Investment Fund investment in Series B - NuProbe
Pappas Capital
Pappas Capital investment in Series B - NuProbe
Ruomu Capital
Ruomu Capital investment in Series B - NuProbe
Official Site Inspections
http://www.nuprobe.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.94 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NuProbe"
NuProbe | Improving analytical sensitivity in DNA biomarkers
At NuProbe, we are developing innovative assays to accelerate cancer research. Our products allow laboratories to detect and quantify low-abundant variants across multiple platforms from …See details»
Improving analytical sensitivity in DNA biomarkers - NuProbe
Using proprietary technologies, NuProbe develops and validates research panels to address unmet needs for detecting and monitoring low-frequency mutations, gene fusions, and copy …See details»
NuProbe - Crunchbase Company Profile & Funding
NuProbe is a cutting-edge genomics and molecular diagnostics company. A technology that blocks amplification of normal DNA sequences while selectively enriching variant sequences, …See details»
Contact us - NuProbe
Connect with us. Email, call, or message us.See details»
NuProbe - LinkedIn
Focused Genomics Panels | NuProbe prototypes and validates high-sensitivity genomics panels for difficult DNA biomarkers including CNVs, gene fusions, and low-frequency mutations.See details»
NuProbe Company Profile 2024: Valuation, Funding
Developer of precision diagnostic technology designed to offer early detection of cancer and infectious diseases.See details»
NuProbe | Fierce Pharma
NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the sensitivity of sequencing mutations and copy …See details»
NuProbe Company Profile - Office Locations, Competitors ... - Craft
NuProbe is a company developing technologies in genomics for disease detection. It develops a PCR-based (polymerase chain reaction) enrichment method called blocker displacement …See details»
NuProbe - VentureRadar
Website: http://www.nuprobe.com/ Develops precision diagnostic technology for early disease detection, treatment, and cure, utilizing genomics and licensed breakthroughs from Harvard …See details»
NuProbe - Funding, Financials, Valuation & Investors - Crunchbase
NuProbe is funded by 16 investors. HongShan and Pan-Lin Capital are the most recent investors. NuProbe has a post-money valuation in the range of $100M to $500M as of Jun 3, 2022, …See details»
Harvard’s Wyss Institute launches NuProbe to facilitate …
Apr 23, 2018 · (BOSTON) — NuProbe Global will commercialize the Wyss Institute’s DNA nanotechnology-based variant-detecting method as a fast, low-cost and multiplexed molecular diagnostic for different disease areas, …See details»
NuProbe - workinbiotech.com
NuProbe is a genomics and molecular diagnostic company enabling diseases to be detected, treated and cured at early stages. NuProbe has proprietary technology to reduce costs and …See details»
Diagnostic Companies-2023 - NuProbe
NuProbe collaborates with diagnostic companies to provide novel solutions to enhance existing platforms and expand test menus. We have developed proprietary technologies to increase …See details»
NuProbe Closes $42M Fundraising - PR Newswire
HOUSTON and SHANGHAI, Jan. 11, 2021 /PRNewswire/ -- NuProbe, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels, announces the closing …See details»
Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement …
Under the terms of the agreement, NuProbe USA will exclusively license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays.See details»
NuProbe technology Enables Rapid Ultrasensitive Mutation …
Sep 6, 2021 · NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular technologies to improve the sensitivity of DNA disease biomarkers by …See details»
NuProbe Technology Enables Low-Frequency DNA Variant …
May 3, 2021 · Data from the study shows that multiplex blocker displacement amplification (mBDA), a library preparation method exclusively licensed and developed by NuProbe, allows …See details»
Products Archives - NuProbe
The first, Non-Extensible Oligonucleotides (NEO), will allow NuProbe to provide much more rapid development of customized NGS panels, with turnaround time of less than 4 weeks. The …See details»
NuProbe Technology Enables Accurate Quantitation of Mutations …
Oct 21, 2021 · NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the sensitivity of sequencing …See details»